Skip to main content
Equibles

Caption Management, LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to VTGN Full portfolio

Position in VTGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,358
-$2,710 QoQ
Shares Held
14,664
-12.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Dec 31, 2025
CallValue
$40,524
CallShares
61,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in VTGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,358 14,664
2025-12-31 $11,068 16,770
2025-12-31 $40,524 61,400
2024-12-31 $147,500 50,000
2024-12-31 $13,157 4,460
2024-09-30 $150,500 50,000
2024-09-30 $13,424 4,460
2022-09-30 $212,519 1,416,800
2022-09-30 $49,373 329,159
2022-06-30 $672,055 763,700
2022-06-30 $296,999 337,500